US and US -based life science company 1Drop has raised $ $4.25 million m to expand the development of its portable diagnostic testing platform, which can analyse a drop of blood and deliver results in 15 minutes . 1DROP eliminates inefficiencies in the healthcare system: 1Drop is planning clinical tests and an application for regulatory approval, and is working with 1Drop pharmaceutical organisations to create similar diagnosis platforms for cardiology, autoimmune disease and glucose metabolism drug test candidates. The series A funding was led by Swiss Startup Factory investor and former Swiss Startup Factory partner Christian Wildmoser with support from fellow Jean-Philippe de Toledo investors Beat Schillig , Jean-Philippe de Toledo and VentureLab .
US and US -based life science company 1Drop has raised $ $4.25 million m to expand the development of its portable diagnostic testing platform, which can analyse a drop of blood and deliver results in 15 minutes . 1Drop is planning clinical tests and an application for regulatory approval, and is working with 1Drop pharmaceutical organisations to create similar diagnosis platforms for cardiology, autoimmune disease and glucose metabolism drug test candidates. The series A funding was led by Swiss Startup Factory investor and former Swiss Startup Factory partner Christian Wildmoser with support from fellow Jean-Philippe de Toledo investors Beat Schillig , Jean-Philippe de Toledo and VentureLab .